SCHEMBL2170398

SCHEMBL2170398

CC1CCN(CC(=O)NC(Cc2ccc(Oc3ccc(F)cc3)cc2)C(N)=O)CC1

nearest known ligand 0.51

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.51
KDM4E B2RXH2 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
SCN9A Q15858 5/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
TSHR P16473 1/20 0.43
HTT P42858 1/20 0.42
CNR2 P34972 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
KCNT1 Q5JUK3 2/20 0.41
RECQL P46063 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2171096 0.89 SCN9A (0.51) ALDH1A1KDM4ESCN9ATSHR
SCHEMBL2350905 0.89 HPGD (0.48) ALDH1A1KDM4ETDP1SCN9ASMN1; SMN2
SCHEMBL2173714 0.87 SCN9A (0.45) ALDH1A1KDM4ESCN9A
SCHEMBL2169958 0.86 SCN9A (0.47) ALDH1A1SCN9ACNR2
SCHEMBL2171621 0.86 QRFPR (0.50) ALDH1A1SCN9A
SCHEMBL2169808 0.86 SCN9A (0.48) ALDH1A1SCN9A
SCHEMBL2171851 0.86 KMT2A (0.53) ALDH1A1SCN9A
SCHEMBL2170108 0.85 LMNA (0.52) ALDH1A1SCN9ASMN1; SMN2HTT
SCHEMBL2185323 0.85 SCN9A (0.45) SCN9ACNR2
SCHEMBL2354557 0.84 KMT2A (0.48) ALDH1A1SCN9ASMN1; SMN2CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2349252-A2 SYNERGISTIC COMBINATION OF SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS AND ANTIMICROTUBULE AGENTS Exelixis, Inc. (US) 2011-08-03 EP disclosed
EP-2346821-A1 SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS Exelixis, Inc. (US) 2011-07-27 EP disclosed
WO-2010045601-A2 SYNERGISTIC EFFECTS BETWEEN SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS AND ANTIMICROTUBULE AGENTS EXELIXIS, INC. (US) 2010-04-22 WO disclosed